2019
DOI: 10.1007/s00406-019-01016-x
|View full text |Cite
|
Sign up to set email alerts
|

A follow-up study of metabolic syndrome in schizophrenia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
5
0
3

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(9 citation statements)
references
References 31 publications
1
5
0
3
Order By: Relevance
“…In patients with SMD, there is a high prevalence of three factors that are key to the development of a MetS: sedentary lifestyles, unbalanced dietary patterns and medication-induced weight gain [ 22 , 23 ]. As we have seen in our study, MetS without intervention increases with follow-up, similar to another study where MetS increased in a group of patients followed for 8 years [ 24 ]. Therefore, dietary modification can help to reduce the components of MetS, especially a reduction of fats (saturated, trans and cholesterol), sodium and sugars, which would help to prevent or control dyslipidemia, hyperglycemia and hypertension [ 25 ].…”
Section: Discussionsupporting
confidence: 91%
“…In patients with SMD, there is a high prevalence of three factors that are key to the development of a MetS: sedentary lifestyles, unbalanced dietary patterns and medication-induced weight gain [ 22 , 23 ]. As we have seen in our study, MetS without intervention increases with follow-up, similar to another study where MetS increased in a group of patients followed for 8 years [ 24 ]. Therefore, dietary modification can help to reduce the components of MetS, especially a reduction of fats (saturated, trans and cholesterol), sodium and sugars, which would help to prevent or control dyslipidemia, hyperglycemia and hypertension [ 25 ].…”
Section: Discussionsupporting
confidence: 91%
“…Применение антипсихотиков сопряжено с развитием ряда нежелательных двигательных эффектов, чаще которых развиваются акатизия -до 76 % [10,11] и метаболические нарушения -от 35 до 56 % [12].…”
Section: оригинальные исследованияunclassified
“…Yazıcı ve arkadaşlarının 2011 yılında yayınladığı çalışmada kliniğimizde 319 şizofreni hastası metabolik sendrom açısından değerlendirilmiş, yaygınlığı ATP-III ölçütlerine göre %34,2, ATP-IIIA ölçütlerine göre %37, IDF ölçütlerine göre %41,7 olarak bildirilmiştir; bu hastalardan %32,6'sının klozapin kullandığı saptanmıştır. Bu çalışmanın devamı niteliğinde bir diğer çalışmada da bu hastaların arasından 149 şizofreni hastası ortalama 8 yıl sonra tekrar değerlendirilmiştir (Yoca ve ark. 2019).…”
Section: Introductionunclassified